NYOH Makes Capital Region History with the First Commercial CAR-T Cancer Treatment Locally
Published Date: April 1, 2025
NCODA member practice, New York Oncology Hematology (NYOH), has achieved a significant milestone by administering the Capital Region’s first commercial CAR-T cell therapy on April 1, 2025, at their Cell Therapy Suite within Albany Medical Center. This groundbreaking immunotherapy involves modifying a patient’s own T-cells to effectively target and eliminate cancer cells. Previously, patients had to travel to distant cities for such advanced treatments; now, NYOH offers this cutting-edge therapy locally, enhancing patient convenience and care. This achievement underscores NYOH’s dedication to pioneering cancer treatments and improving accessibility for their patients.